
Sign up to save your podcasts
Or


GlaxoSmithKline takes on Pfizer and Biogen battles Celgene in this healthcare edition of Industry Focus.
Big changes are happening in the world of entertainment and coffee consumption, here’s how investors can position their portfolios.
There's reason to believe that they will.
It's been nearly eight years since the financial crisis, yet Bank of America (NYSE: BAC) is still earning half as much money as it should be given its size. In this episode of Industry Focus: Financials, The Motley Fool's Gaby Lapera and John Maxfield discuss the role that Bank of America's 2008 purchase of Merrill Lynch plays in its subpar profitability. Thanks to Audible for supporting this episode. Get a free 30-day trial at audible.com/fool.
We discuss stock splits, the strategy behind them, and why Facebook announced they were using C shares to offer investors a 3-to-1 split.
If Tesla Motors plans for growth and its new Model 3 weren't ambitious enough, it now wants to make it all happen by 2018. Plus, earnings from Royal Dutch Shell, BHP Billiton & Vale's nightmare situation, and we dip into the mailbag.
From the publisher's feed

3,155 Listeners

806 Listeners

933 Listeners

1,604 Listeners